Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
NEW YORK, Jan. 21, 2014 /PRNewswire/ -- Anne Wilkins joined AllazoHealth this week as an advisory board member.
Ms. Wilkins has more than 20 years of healthcare experience. She was Partner and Managing Director at BCG until 2008, leading the North American Health Care Payer Practice, which was the fastest growing sector of the health care practice during her tenure. She's also the former Chief Strategy and Chief Marketing Officer of Healthways, a population health management company. Ms. Wilkins currently runs her own company, Wilkins Advisors, LLC, a consulting and strategic advisory firm that helps health care companies find growth opportunities and solve strategic challenges.
"Anne is a healthcare executive with a long history of leadership in population health management. We are excited that she has joined our team to help fuel our continued growth," said Clifford Jones, CEO of AllazoHealth.
"Medication adherence is a critical part of improving health and quality while lowering total health care cost. Increasingly, advanced analytics are required to not only more quickly identify who is struggling with medication adherence, but also more effectively help through individually customized support. I am pleased to be advising AllazoHealth, which is leading the way on these advanced dimensions," said Anne Wilkins, Managing Director of Wilkins Advisors.
Ms. Wilkins holds a Master of Business Administration from The Wharton School of the University of Pennsylvania and a Bachelor of Science in Finance from the University of Connecticut.
AllazoHealth is an analytics firm that is helping to crack down on the overwhelming issue of medication non-adherence in the United States, which results in as much as $290 billion in avoidable costs annually. AllazoHealth's proprietary AllazoEngine™ combines cutting-edge behavioral science research, industry expertise, and advanced predictive analytics to both anticipate medication non-adherence and forecast the most effective intervention strategy for each individual patient. Health insurers, pharmacy benefit management companies, and accountable care organizations benefit significantly from AllazoHealth's technology. When patients take their medications as prescribed, patient health improves and more expensive care is avoided, decreasing overall health care costs. In addition, improved medication adherence increases HEDIS scores and Medicare star ratings. More information about AllazoHealth can be found at http://www.allazohealth.com.
CONTACT: Rebecca Elwork, (888) 464-2776 ext. 708, firstname.lastname@example.org
©2012 PR Newswire. All Rights Reserved.